Smoking Cessation

Psychiatry·MeSH: Smoking Cessation

10 drugs in development·10 companies·28 clinical trials

Drug Pipeline by Phase

Approved(6)

Drug	Company
exforge hct	Novartis AG (NVS)
losartan	Teva Pharmaceutical Industries Limited (TEVA)
nebivolol	ANI PHARMACEUTICALS INC (ANIP)
olmesartan medoxomil	Amneal Pharmaceuticals, Inc. (AMRX)
telmisartan	Inventiva S.A. (IVA)
varenicline	DR REDDYS LABORATORIES LTD (RDY)

Phase 2(1)

Drug	Company
Varenicline	Merus N.V. (MRUS)

Preclinical(1)

Drug	Company
skny-1	MIRA PHARMACEUTICALS, INC. (MIRA)

Phase 4(2)

Drug	Company
cytisinicline	ACHIEVE LIFE SCIENCES, INC. (ACHV)
nicotine lozenge	GH Research PLC (GHRS)

BioSniper tracks 10 drugs in development for Smoking Cessation across 10 companies.

There are 28 clinical trials targeting Smoking Cessation tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.